Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Martina Montagnana, Elisa Danese, Giuseppe Lippi & Cristiano Fava. (2017) Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks?. Annals of Medicine 49:3, pages 240-253.
Read now
Read now
Rosemary Townsend, Patrick O’Brien & Asma Khalil. (2016) Current best practice in the management of hypertensive disorders in pregnancy. Integrated Blood Pressure Control 9, pages 79-94.
Read now
Read now
Elena R. Rivers, Anthony J. Horton, Angela F. Hawk, Elizabeth G. Favre, Katherine M. Senf, Paul J. Nietert, Eugene Y. Chang, Ann C. Foley, Christopher J. Robinson & Kyu-Ho Lee. (2014) Placental Nkx2-5 and target gene expression in early-onset and severe preeclampsia. Hypertension in Pregnancy 33:4, pages 412-426.
Read now
Read now
Articles from other publishers (25)
Sara Caamiña Álvarez, Alicia Rodríguez Zurita, Tania del Carmen De Ganzo Suárez, José Fernando De Luis Escudero, Nieves Sierra Medina, Carolina Chulilla Pérez, Cecilia Martín Fernández de Basoa, José Luis Trabado Montesino, María Teresa Concepción Masip & Miguel Ángel García Bello. (2023) Is a sFlt-1/PlGF cutoff of 38 suitable to predict adverse outcomes in pregnancies with abnormal uterine artery Doppler velocimetry in the second trimester?. Pregnancy Hypertension 34, pages 13-18.
Crossref
Crossref
Almudena Lara-Barea, Begoña Sánchez-Lechuga, Manuel Aguilar-Diosdado & Cristina López-Tinoco. (2022) Higher daytime systolic BP, prepregnancy BMI and an elevated sFlt-1/PlGF ratio predict the development of hypertension in normotensive pregnant women. Reproductive Biology and Endocrinology 20:1.
Crossref
Crossref
Lisa Antonia Lorenz-Meyer, Lisa Frank, Dorota Sroka, Andreas Busjahn, Wolfgang Henrich & Stefan Verlohren. (2022) Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction. Pregnancy Hypertension 28, pages 149-155.
Crossref
Crossref
Ruqaiya Shahid, Muhammad F. Bari & Mehwish Hussain. (2022) Serum biomarkers for the prediction and diagnosis of preeclampsia: A meta-analysis. Journal of Taibah University Medical Sciences 17:1, pages 14-27.
Crossref
Crossref
Yonggang Zhang, Yipeng Zhang, Limin Zhao, Junzhu Shi & Hongling Yang. (2021) Plasma SerpinA5 in conjunction with uterine artery pulsatility index and clinical risk factor for the early prediction of preeclampsia. PLOS ONE 16:10, pages e0258541.
Crossref
Crossref
Kristina Kumer, Adi Sharabi-Nov, Vesna Fabjan Vodušek, Tanja Premru Sršen, Nataša Tul, Teja Fabjan, Hamutal Meiri, Kypros Herodotos Nicolaides & Joško Osredkar. (2021) Pro- and Anti-Angiogenic Markers as Clinical Tools for Suspected Preeclampsia with and without FGR near Delivery—A Secondary Analysis. Reproductive Medicine 2:1, pages 12-25.
Crossref
Crossref
Adam Morton, Michael Burke, Elizabeth Jarvis & Sailesh Kumar. (2020) Changes in proteinuria and diagnosing preeclampsia in CKD pregnancy. Pregnancy Hypertension 20, pages 92-95.
Crossref
Crossref
Adi Sharabi-Nov, Kristina Kumar, Vesna Fabjan Vodušek, Tanja Premru Sršen, Nataša Tul, Teja Fabjan, Hamutal Meiri, Kypros H. Nicolaides & Joško Osredkar. (2020) Establishing a Differential Marker Profile for Pregnancy Complications Near Delivery. Fetal Diagnosis and Therapy 47:6, pages 471-484.
Crossref
Crossref
Sabine Enengl, Richard B. Mayer, Pol-Edern Le Renard, Omar Shebl, Wolfgang Arzt & Peter Oppelt. (2020) Retrospective evaluation of established cut-off values for the sFlt-1/PlGF ratio for predicting imminent delivery in preeclampsia patients. Pregnancy Hypertension 19, pages 143-149.
Crossref
Crossref
Rosemary Townsend & Asma Khalil. 2020. Maternal-Fetal and Neonatal Endocrinology. Maternal-Fetal and Neonatal Endocrinology
455
483
.
Osredkar Joško & Kumer Kristina. 2019. Prediction of Maternal and Fetal Syndrome of Preeclampsia. Prediction of Maternal and Fetal Syndrome of Preeclampsia.
M. Barjaktarovic, T. I. M. Korevaar, V. W. V. Jaddoe, Y. B. Rijke, R. P. Peeters & E. A. P. Steegers. (2019) Human chorionic gonadotropin and risk of pre‐eclampsia: prospective population‐based cohort study. Ultrasound in Obstetrics & Gynecology 54:4, pages 477-483.
Crossref
Crossref
Amr Hamza, Ch. Gerlinger, J. Radosa, E. F. Solomayer, J. Hagmann, U. Sester, R. Bohle, R. Stroeder, Z. Takacs, G. Meyberg-Solomayer, I. Juhasz-Boess & M. Kasoha. (2019) Pilot study: placental biomarker predictive capability (sFlt-1, PlGF and their ratio) of postpartum maternal outcome. Archives of Gynecology and Obstetrics 299:6, pages 1557-1566.
Crossref
Crossref
Ruby Minhas, Danielle Young, Rabab Naseem, Ariel Mueller, Sireesha Chinthala, Joana Lopes Perdigao, Kiang-Teck J. Yeo, Siaw Li Chan, Avery Tung, Julia Bregand White, Sajid Shahul & Sarosh Rana. (2018) Association of antepartum blood pressure levels and angiogenic profile among women with chronic hypertension. Pregnancy Hypertension 14, pages 110-114.
Crossref
Crossref
Sang Jin Kim, Alexander D. Port, Ryan Swan, J. Peter Campbell, R.V. Paul Chan & Michael F. Chiang. (2018) Retinopathy of prematurity: a review of risk factors and their clinical significance. Survey of Ophthalmology 63:5, pages 618-637.
Crossref
Crossref
Sarosh Rana, Saira Salahuddin, Ariel Mueller, Anders H. Berg, Ravi I. Thadhani & S. Ananth Karumanchi. (2018) Angiogenic biomarkers in triage and risk for preeclampsia with severe features. Pregnancy Hypertension 13, pages 100-106.
Crossref
Crossref
Carin Black & Fabricio da Silva Costa. 2018. Preeclampsia. Preeclampsia
9
26
.
Elizabeth V. Schulz, Lori Cruze, Wei Wei, John Gehris & Carol L. Wagner. (2017) Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy. The Journal of Steroid Biochemistry and Molecular Biology 173, pages 273-279.
Crossref
Crossref
TingTing Zhu, Li Zhang, FengYan Zhao, Yi Qu & Dezhi Mu. (2017) Association of maternal hypertensive disorders with retinopathy of prematurity: A systematic review and meta-analysis. PLOS ONE 12:4, pages e0175374.
Crossref
Crossref
Geoff K Frampton, Jeremy Jones, Micah Rose & Liz Payne. (2016) Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment 20:87, pages 1-160.
Crossref
Crossref
Sajid ShahulDiego MedvedofskyJulia B. WengerJunaid NizamuddinSamuel M. BrownSurichhya BajracharyaSaira SalahuddinRavi ThadhaniAriel MuellerAvery TungRoberto M. LangZoltan AranyDaniel TalmorS. Ananth KarumanchiSarosh Rana. (2016) Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy. Hypertension 67:6, pages 1273-1280.
Crossref
Crossref
Rosemary Townsend, Patrick O'Brien & Asma Khalil. (2015) Diagnosis and management of pre-eclampsia: A clinical perspective on recent advances in the field. British Journal of Midwifery 23:4, pages 252-258.
Crossref
Crossref
L. Dröge, I. Herraìz, H. Zeisler, D. Schlembach, H. Stepan, L. Küssel, W. Henrich, A. Galindo & S. Verlohren. (2015)
Maternal serum
sFlt
‐1/
PlGF
ratio in twin pregnancies with and without pre‐eclampsia in comparison with singleton pregnancies
. Ultrasound in Obstetrics & Gynecology 45:3, pages 286-293.
Crossref
Crossref
Juha Rasanen, Matthew J. Quinn, Amber Laurie, Eric Bean, Charles T. RobertsJr.Jr., Srinivasa R. Nagalla & Michael G. Gravett. (2015) Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia. American Journal of Obstetrics and Gynecology 212:1, pages 82.e1-82.e9.
Crossref
Crossref
Stefan VerlohrenIgnacio HerraizOlav LapaireDietmar SchlembachHarald ZeislerPavel CaldaJoan SabriaFiliz Markfeld-ErolAlberto GalindoKatharina SchoofsBarbara DenkHolger Stepan. (2014) New Gestational Phase–Specific Cutoff Values for the Use of the Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia. Hypertension 63:2, pages 346-352.
Crossref
Crossref